Financial Year |
March 31 2023 |
Monetary Funds |
1,465,755,897.50 |
Held-for-trading Financial Assets |
21,907,200.00 |
Notes Receivable |
-- |
Accounts Receivable |
1,731,646,124.96 |
Advances to Suppliers |
51,999,813.03 |
Other Receivables |
643,485,004.69 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,411,069,866.94 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
49,036,625.40 |
Total Current Assets |
6,821,658,184.79 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
298,357,322.29 |
Investment Properties |
40,313,973.92 |
Fixed Assetes |
917,836,259.95 |
Under-construction Projects |
141,023,730.76 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
179,596,218.18 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
19,296,051.98 |
Deferred Income Tax Assets |
46,171,403.88 |
Other Non-Current Assets |
97,377,956.84 |
Sub-Total of Non-Current Assets |
1,916,012,200.50 |
Total Assets |
8,737,670,385.29 |
Short-Term Loans |
1,165,893,975.00 |
Trading Financial liabilities |
-- |
Notes Payable |
699,332,743.64 |
Accounts Payable |
1,840,042,447.44 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
201,042,984.77 |
Taxes Payable |
105,897,231.42 |
Interest Payable |
-- |
Dividend Payable |
3,182,036.73 |
Other payables |
316,886,370.58 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
70,738,780.02 |
Other Current Liabilities |
152,891,420.41 |
Sub-Total of Current Liabilities |
4,638,257,846.69 |
Long-term Loans |
200,204,722.22 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,335,495.95 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
399,740,315.27 |
Total Liabilities |
5,037,998,161.96 |
Paid-In Capital(Or Share Stock) |
1,056,626,982.00 |
Capital Surplus |
3,013,345,265.36 |
Surplus Reserve |
139,510,711.46 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-430,247,452.42 |
Minority Stockholder's Interest |
-105,820,932.86 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,805,493,156.19 |
Owner's Equity(Stockholder's Equity) |
3,699,672,223.33 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
8,737,670,385.29 |